Courts
It's the busiest day of the legal year, but all eyes are on a trio of fascinating High Court cases set down for 2026.
The two companies have both issued termination notices, but which one is valid remains up for debate.
Australia’s electronic property settlements giant wants to pass a data standards licensing fee on to customers. But NSW isn't playing ball.
It takes special talent to go backwards on an appeal, but that's what happened to Bruce Lehrmann this week.
The High Court's December docket also includes a test for the federal government's move to send immigration detainees to Nauru.
Capital Brief interviewed the High Court chief justice at the Australian Legal Convention.
The High Court chief justice opened the Australian Legal Convention saying the issue is “nothing short of critical” and arguing the Voice loss must not silence reform.
The Commonwealth may have “won” the Russian embassy case in the High Court, but it will still have to fork out millions in compensation.
The tax office wanted to settle a royalty battle with US tech giant Oracle in the courts. Now it has been stymied by an appeal court and a tax treaty with Ireland.
Taking hackers to court has become a standard part of the cyber response toolkit since law firm HWL Ebsworth was attacked in 2023. But for those still paying ransoms, the price has only risen.
After a long campaign fought largely out of the headlines, judges are celebrating the demise of the proposed tax on their pensions.
After three weeks in court, Mayne Pharma and Cosette Pharmaceuticals await a ruling that could decide their $672m deal’s fate, with FIRB approval still pending.
High Court justice Simon Steward says it is "only a matter of time" before directors face court for involving their companies in social and political debates.
Clive Palmer’s costly tilt at Australia over whether he qualifies as a foreign investor ended in defeat. But will the country retrieve its $13.6 million in costs?
The NSW Supreme Court is teaching court reporting to journalism students with the help of former judge Richard Button. Capital Brief sat in on the latest lecture.
Investors and lawyers say US-based Cosette's attempt to back out of a takeover of Mayne Pharma will reshape the way deals are done on the ASX whether it succeeds or not.
